Event
BioEquity
📅 Date: May 12-14, 2025
📍 Location: Bruges, Belgium
Meet Axxam in Bruges
Atf Nagbou, BD Senior Director
Advancing Drug Discovery at BioEquity 2025
Axxam is pleased to announce our participation in BioEquity 2025, taking place from May 12 to 14 in the beautiful city of Bruges, Belgium. As Europe’s premier event for biotech investment and strategic partnering, BioEquity gathers high-potential companies, venture capitalists, and R&D leaders shaping the future of life sciences.
With a strong track record in early-stage drug discovery, Axxam partners with biotech companies across therapeutic areas to support the generation of high-quality data that strengthens scientific value and investor confidence.
Scientific services that add strategic value
Whether you are preparing for your next investment round or advancing assets toward the clinic, Axxam delivers discovery programs tailored to support your growth and scientific credibility.
Our core capabilities include:
Custom assay development and compound screening
High-content and high-throughput screening (HCS & HTS)
iPSC-derived cell models for disease-relevant biology
Hit qualification and hit-to-lead optimization
We work side by side with our partners to transform ideas into validated leads, using flexible and collaborative models that fit the needs of biotech innovators.
Let’s connect in Bruges
Are you attending BioEquity 2025? Let’s schedule a meeting to discuss how Axxam’s discovery expertise can support your R&D goals and strengthen your positioning with investors and strategic partners.
👉 Book a meeting today and let’s start a conversation.